Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
Condition(s):Non-24-Hour-Sleep-Wake DisorderLast Updated:August 22, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Non-24-Hour-Sleep-Wake DisorderLast Updated:August 22, 2016Completed
Condition(s):REM Behavior DisorderLast Updated:June 29, 2023Not yet recruiting
Condition(s):Hepatic ImpairmentLast Updated:February 17, 2014Completed
Condition(s):Autism Spectrum Disorder; Sleep Disorder; Neurological Disorder; Sleep DisturbanceLast Updated:March 21, 2024Recruiting
Condition(s):Healthy VolunteersLast Updated:February 17, 2014Completed
Condition(s):Circadian Rhythm Sleep Disorders; Non-24 Hour Sleep-Wake Disorder; Autism Spectrum Disorder; Smith-Magenis SyndromeLast Updated:March 21, 2024Completed
Condition(s):HealthyLast Updated:March 21, 2024Completed
Condition(s):Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With EthanolLast Updated:February 17, 2014Completed
Condition(s):Non-24-Hour Sleep-Wake DisorderLast Updated:April 21, 2015Completed
Condition(s):Non 24 Hour Sleep Wake DisorderLast Updated:November 17, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.